Dr Reddy’s and Fresenius Kabi get US FDA approval for generic Femara

The US Food and Drug Administration gave approval to Dr Reddy’s Laboratories and Fresenius Kabi Oncology, both listed Indian pharmaceutical companies, to market cancer drug letrozole or the generic version of Femara in the US. Novartis owns the patent for Femara, a drug used to treat breast cancer in post-menopausal women, which earned US-market sales of $682 million or Rs 3,100 crore in 2010.

Continue Reading

L&T wins Rs 1,450 crore 2-yr GSPC offshore platform project

Larsen & Toubro will build an offshore platform -process and living quarters- for Gujarat State Petroleum Corporation. The platform will be commissioned at KG6 at the Deen Dayal Field from where GSPC intends to start gas production from July 2013. Earlier, L&T had got the contract to construct the wellhead platform for the development of this field. The gas field will be able to generate 6 million standard cubic metres of gas per day.

Continue Reading